ask="3.3300"
ask_size="100"
average_daily_volume="9643"
bid="N/A"
bid_size="N/A"
book_value="2.2200"
change="+0.0099"
change_from_200_day_moving_average="-0.6394"
change_from_50_day_moving_average="-0.0327"
change_from_52_week_high="-2.3801"
change_From_52_week_low="0.7098"
change_in_percent="+0.2991%"
close="3.3199"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.7370"
ebitda="-19.08M"
eps_estimate_current_year="-1.8000"
eps_estimate_next_quarter="-0.4100"
eps_estimate_next_year="-1.7000"
ex_dividend_date="N/A"
float_shares="1799000"
high="3.3500"
high_52_weeks="5.7000"
last_trade_date="3/1/2017"
last_trade_price="3.3199"
last_trade_size="200"
last_trade_time="3:57pm"
low="3.2500"
low_52_weeks="2.6101"
market_capitalization="39.02M"
moving_average_200_day="3.9593"
moving_average_50_day="3.3526"
name="Nexvet Biopharma plc"
notes="N/A"
one_year_target_price="8.0000"
open="3.3000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-16.1485%"
percent_change_from_50_day_moving_average="-0.9768%"
percent_change_from_52_week_high="-41.7561%"
percent_change_from_52_week_low="+27.1944%"
previous_close="3.3100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.4910"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11752000"
short_ratio="9.5500"
stock_exchange="NGM"
symbol="NVET"
volume="32491"
weeks_range_52="2.6101 - 5.7000"
